| Application number | Title of the application | Filing Date | Status |
|---|
Array
(
[id] => 4103546
[patent_doc_number] => 06066778
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-05-23
[patent_title] => 'Transgenic mice expressing APC resistant factor V'
[patent_app_type] => 1
[patent_app_number] => 8/746111
[patent_app_country] => US
[patent_app_date] => 1996-11-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 16
[patent_no_of_words] => 34701
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/066/06066778.pdf
[firstpage_image] =>[orig_patent_app_number] => 746111
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/746111 | Transgenic mice expressing APC resistant factor V | Nov 5, 1996 | Issued |
Array
(
[id] => 3831666
[patent_doc_number] => 05814500
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-09-29
[patent_title] => 'Delivery construct for antisense nucleic acids and methods of use'
[patent_app_type] => 1
[patent_app_number] => 8/742943
[patent_app_country] => US
[patent_app_date] => 1996-10-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 8651
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 95
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/814/05814500.pdf
[firstpage_image] =>[orig_patent_app_number] => 742943
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/742943 | Delivery construct for antisense nucleic acids and methods of use | Oct 30, 1996 | Issued |
Array
(
[id] => 3992896
[patent_doc_number] => 05919702
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-07-06
[patent_title] => 'Production of cartilage tissue using cells isolated from Wharton\'s jelly'
[patent_app_type] => 1
[patent_app_number] => 8/735620
[patent_app_country] => US
[patent_app_date] => 1996-10-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 15
[patent_no_of_words] => 17074
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/919/05919702.pdf
[firstpage_image] =>[orig_patent_app_number] => 735620
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/735620 | Production of cartilage tissue using cells isolated from Wharton's jelly | Oct 22, 1996 | Issued |
| 08/687458 | CELL LINES, MATURATION FACTORS AND USE OF SAID CELL LINES AND FACTORS | Oct 21, 1996 | Abandoned |
Array
(
[id] => 4007791
[patent_doc_number] => 05859314
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-01-12
[patent_title] => 'Mice with targeted tyrosine kinase, lyn, disruption'
[patent_app_type] => 1
[patent_app_number] => 8/730876
[patent_app_country] => US
[patent_app_date] => 1996-10-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 31
[patent_no_of_words] => 11360
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 57
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/859/05859314.pdf
[firstpage_image] =>[orig_patent_app_number] => 730876
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/730876 | Mice with targeted tyrosine kinase, lyn, disruption | Oct 17, 1996 | Issued |
Array
(
[id] => 4292204
[patent_doc_number] => 06211427
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-04-03
[patent_title] => 'Peptide production as fusion protein in transgenic mammal milk'
[patent_app_type] => 1
[patent_app_number] => 8/727153
[patent_app_country] => US
[patent_app_date] => 1996-10-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4974
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 124
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/211/06211427.pdf
[firstpage_image] =>[orig_patent_app_number] => 727153
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/727153 | Peptide production as fusion protein in transgenic mammal milk | Oct 7, 1996 | Issued |
| 08/726531 | IMMUNE-PRIVILEGED CELLS FOR SYSTEMIC DELIVERY OF BIOMOLECULES AND TREATMENT OF DISEASE | Oct 6, 1996 | Abandoned |
Array
(
[id] => 4067391
[patent_doc_number] => 05866756
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-02-02
[patent_title] => 'Dopamine transporter knockout mice'
[patent_app_type] => 1
[patent_app_number] => 8/724405
[patent_app_country] => US
[patent_app_date] => 1996-10-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 5710
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 52
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/866/05866756.pdf
[firstpage_image] =>[orig_patent_app_number] => 724405
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/724405 | Dopamine transporter knockout mice | Oct 1, 1996 | Issued |
| 08/716348 | HIGH EFFICIENCY TRANSDUCTION OF HEMATOPOIETIC CELLS, INCLUDING PLURIPOTENT HEMATOPOIETIC STEM CELLS (PHSCS) | Sep 26, 1996 | Abandoned |
Array
(
[id] => 4237199
[patent_doc_number] => 06080569
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-06-27
[patent_title] => 'Adenovirus vectors generated from helper viruses and helper-dependent vectors'
[patent_app_type] => 1
[patent_app_number] => 8/719217
[patent_app_country] => US
[patent_app_date] => 1996-09-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 15
[patent_no_of_words] => 9283
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 62
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/080/06080569.pdf
[firstpage_image] =>[orig_patent_app_number] => 719217
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/719217 | Adenovirus vectors generated from helper viruses and helper-dependent vectors | Sep 24, 1996 | Issued |
Array
(
[id] => 3862037
[patent_doc_number] => 05792902
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-08-11
[patent_title] => 'Dyslipoproteinaemia-sensitized transgenic rabbit'
[patent_app_type] => 1
[patent_app_number] => 8/704582
[patent_app_country] => US
[patent_app_date] => 1996-09-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 4769
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 67
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/792/05792902.pdf
[firstpage_image] =>[orig_patent_app_number] => 704582
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/704582 | Dyslipoproteinaemia-sensitized transgenic rabbit | Sep 19, 1996 | Issued |
| 08/715318 | RETROVIRAL VECTORS CAPABLE OF TRANSDUCING NON-DIVIDING CELLS | Sep 16, 1996 | Abandoned |
| 08/716443 | ALPHA(1,3) GALACTOSYLTRANSFERASE NEGATIVE SWINE | Sep 15, 1996 | Abandoned |
| 08/712614 | THERAPY FOR A-GALACTOSIDASE A DEFICIENCY | Sep 12, 1996 | Abandoned |
| 08/704567 | ALPHAVIRUS CDNA VECTORS | Sep 9, 1996 | Abandoned |
Array
(
[id] => 3861654
[patent_doc_number] => 05837220
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-11-17
[patent_title] => 'Method for analyzing the immunosuppressant activity of ion channel blockers using the mini-pig'
[patent_app_type] => 1
[patent_app_number] => 8/711576
[patent_app_country] => US
[patent_app_date] => 1996-09-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 2992
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 208
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/837/05837220.pdf
[firstpage_image] =>[orig_patent_app_number] => 711576
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/711576 | Method for analyzing the immunosuppressant activity of ion channel blockers using the mini-pig | Sep 9, 1996 | Issued |
Array
(
[id] => 3982588
[patent_doc_number] => 05948952
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-09-07
[patent_title] => 'Xeroderma pigmentosum-deficient mouse'
[patent_app_type] => 1
[patent_app_number] => 8/708958
[patent_app_country] => US
[patent_app_date] => 1996-09-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 8
[patent_no_of_words] => 9939
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/948/05948952.pdf
[firstpage_image] =>[orig_patent_app_number] => 708958
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/708958 | Xeroderma pigmentosum-deficient mouse | Sep 5, 1996 | Issued |
Array
(
[id] => 3986036
[patent_doc_number] => 05891455
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-04-06
[patent_title] => 'Process for producing an implant from cell cultures'
[patent_app_type] => 1
[patent_app_number] => 8/513995
[patent_app_country] => US
[patent_app_date] => 1996-09-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 2329
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 77
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/891/05891455.pdf
[firstpage_image] =>[orig_patent_app_number] => 513995
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/513995 | Process for producing an implant from cell cultures | Sep 5, 1996 | Issued |
Array
(
[id] => 4064924
[patent_doc_number] => 05895759
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-04-20
[patent_title] => 'Vector for gene transfer in liver cells'
[patent_app_type] => 1
[patent_app_number] => 8/697998
[patent_app_country] => US
[patent_app_date] => 1996-09-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1810
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 86
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/895/05895759.pdf
[firstpage_image] =>[orig_patent_app_number] => 697998
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/697998 | Vector for gene transfer in liver cells | Sep 2, 1996 | Issued |
Array
(
[id] => 4010939
[patent_doc_number] => 05879905
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-03-09
[patent_title] => 'In vivo method of initiating protein synthesis with an amino acid other than methionine'
[patent_app_type] => 1
[patent_app_number] => 8/705196
[patent_app_country] => US
[patent_app_date] => 1996-08-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 4
[patent_no_of_words] => 4127
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 135
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/879/05879905.pdf
[firstpage_image] =>[orig_patent_app_number] => 705196
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/705196 | In vivo method of initiating protein synthesis with an amino acid other than methionine | Aug 28, 1996 | Issued |